Hepatic Arterial Infusion Chemotherapy in Patients With Inoperable Colorectal Cancer Liver Metastasis

The goal of this clinical trial is to assess how many patients with initially inoperable colorectal liver metastasis are able to have a liver surgery after treatment with hepatic artery infusion chemotherapy and standard of care systemic chemotherapy.

Trial Details

NCT ID
NCT07764497
Phase
PHASE2
Sponsor
Sunnybrook Health Sciences Centre
Status
RECRUITING
Cancer Type
Liver Cancer
Interventions
  • Floxuridine (FUDR)
Locations (sample)
  • Toronto, Ontario, Canada|43.70643,-79.39864

Key Eligibility Criteria

  • History of histologically confirmed colorectal adenocarcinoma metastatic to the liver with no clinical or radiographic evidence of extrahepatic dis…
  • Physically able to tolerate major partial hepatectomy.
  • The primary tumor may be in place at the time of registration if not obstructing the intestinal lumen or significantly bleeding. If present, the pr…
  • Chest, Abdominal and Pelvic CT scan with CT angiogram within 6 weeks prior to registration. (MRI angiogram with contrast of the abdomen may be subs…

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Liver Cancer Trials on Trialify →